NCT03233906

Brief Summary

The purpose of the study is to examine the effect of chia seed consumption on body composition, blood pressure, blood glucose, satiety, mood, joint pain, and dietary displacement in overweight and obese females (18-45years). It is hypothesized that consuming chia seeds will bring about a positive change in body composition (lower % body fat), satiety, mood, joint pain, and blood pressure, lower blood glucose levels, increased fiber and improved nutrient intake, in overweight/ obese females.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started May 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 17, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 31, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

May 11, 2018

Status Verified

May 1, 2018

Enrollment Period

12 months

First QC Date

July 17, 2017

Last Update Submit

May 8, 2018

Conditions

Outcome Measures

Primary Outcomes (24)

  • Fasting plasma glucose

    12-hour fasting plasma glucose levels will be assessed using a glucometer

    baseline

  • Waist Circumference

    waist circumference will be measured for each participant

    baseline

  • Caloric intake

    9, 3-day diet journals will be collected using a paper method

    baseline

  • Serotonin

    Urine serotonin levels will be assessed

    baseline

  • Body Weight

    Tanita scale

    Baseline

  • Body Mass Index

    Tanita sclae

    Baseline

  • Body Fat Percentage

    Tanita scale

    Baseline

  • Fasting plasma glucose

    2-hour fasting plasma glucose levels will be assessed using a glucometer

    week 4

  • Fasting plasma glucose

    2-hour fasting plasma glucose levels will be assessed using a glucometer

    week 8

  • Waist Circumference

    waist circumference will be measured for each participant

    week 4

  • Waist Circumference

    waist will be measured for each participant

    week 8

  • Caloric intake

    9, 3-day diet journals will be collected using a paper method

    week 4

  • Caloric intake

    9, 3-day diet journals will be collected using a paper method

    week 8

  • Serotonin

    Urine serotonin levels will be assessed

    week 4

  • Serotonin

    Urine serotonin levels will be assessed

    week 8

  • Body Weight

    tanita scale

    week 4

  • Body weight

    tanita scale

    week 8

  • Body mass index

    tanita scale

    week 4

  • body mass index

    tanita scale

    week 8

  • Body fat percentage

    tanita scale

    week 4

  • Body fat percentage

    tanita scale

    week 8

  • Hip Circumference

    Hip Circumference will be measured for each participant

    Baseline

  • Hip Circumference

    Hip Circumference will be measured for each participant

    week 4

  • Hip Circumference

    Hip Circumference will be measured for each participant

    week 8

Secondary Outcomes (36)

  • Blood Pressure

    baseline

  • Blood Pressure

    week 4

  • Blood Pressure

    week 8

  • Joint Pain

    baseline

  • Joint Pain

    week 4

  • +31 more secondary outcomes

Study Arms (2)

Chia Seeds

ACTIVE COMPARATOR

10% of a participants total kcal estimated needs given in chia seeds everyday for 8 weeks.

Dietary Supplement: Chia Seeds- Salvia Hispanica

Control

NO INTERVENTION

Habitual diet with avoidance of high fiber and high omega-3 fatty acid foods.

Interventions

Chia seed added-10% of kcals and a no-chia control diet. 10% will be calculated using the following formula: Harris-Benedict equation multiplied by the activity factor of 1.2, 1.375, and 1.55 depending on each participant's activity level based on the information provided on the initial screening form.

Chia Seeds

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • are a female.
  • are between the ages of 18 and 45.
  • are not averse to consuming chia seeds on a regular basis (at least six weeks).
  • have not taken any medication for any chronic disease (heart, diabetes, cancer) for twelve weeks.
  • have not taken any steroid or hormone medication in the last eight weeks, excluding birth control pills...
  • do not consume excess amounts of nuts and seeds. - do not consume alcohol on a regular basis.
  • are not currently on a diet plan.
  • are not pregnant or plan to become pregnant.

You may not qualify if:

  • are a child, teenager, woman, or male younger than 18 or older than 45.
  • eat large quantities of chia seeds on a regular basis.
  • are taking any steroid or hormone medication (other than birth control pills). - are taking laxatives or fiber containing supplements on a regular basis.
  • are pregnant or become pregnant.
  • are currently on a diet plan.
  • have a known allergy to seeds.
  • consume excess amounts of seeds or nuts.
  • consume alcohol on a regular basis.
  • have a pacemaker or metal pins or plates in the body.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

California State Polytechnic University, Pomona

Pomona, California, 91766, United States

Location

MeSH Terms

Conditions

ObesityFeeding Behavior

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior, AnimalBehavior

Study Officials

  • Bonny Burns-Whitmore, DrPh, RD

    California State Polytechnic University, Pomona

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Human subjects- females (18-45 y.o.) with a BMI greater than or equal to 26.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Graduate Student, Human Nutrition and Food Science

Study Record Dates

First Submitted

July 17, 2017

First Posted

July 31, 2017

Study Start

May 20, 2017

Primary Completion

May 1, 2018

Study Completion

August 1, 2018

Last Updated

May 11, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations